Bank of Montreal’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-9,700
Closed -$3.41M – 3838
2026
Q1
$3.41M Buy
9,700
+7,500
+341% +$2.67M ﹤0.01% 1466
2025
Q4
$720K Buy
+2,200
New +$698K ﹤0.01% 2145
2024
Q1
– Sell
-19,500
Closed -$5.63M – 3856
2023
Q4
$5.63M Buy
19,500
+6,900
+55% +$1.88M ﹤0.01% 1231
2023
Q3
$3.3M Buy
+12,600
New +$3.14M ﹤0.01% 1463
2022
Q2
– Sell
-29,000
Closed -$7.4M – 4061
2022
Q1
$7.4M Buy
+29,000
New +$6.66M ﹤0.01% 1293

Other funds holding AMGN

Bank of Montreal's AMGN Position: Q2 2026 in Review

Bank of Montreal reduced its Amgen (AMGN) stake by 8.2% in Q2 2026, selling an estimated $27M and leaving 882,230 shares worth $319M. The position accounts for 0.11% of the portfolio, ranked #153.

Bank of Montreal first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $602M in Q2 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bank of Montreal held 882,230 shares of Amgen worth $319M as of Q2 2026.
  • Bank of Montreal sold 78,935 Amgen shares in Q2 2026, an estimated $27M.
  • Amgen made up 0.11% of Bank of Montreal's portfolio in Q2 2026, its #153 holding.
  • Bank of Montreal first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Amgen position peaked at $602M in Q2 2021.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.